Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.04% |
| 2 | Healthcare | 13.57% |
| 3 | Technology | 12.05% |
| 4 | Financials | 10.74% |
| 5 | Consumer Discretionary | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
PUT
Chipotle Mexican Grill
CMG
$47.1B
| $2.63M | ﹤0.01% |
+185,000
| New | +$2.15M |
|
|
NESR
2202
National Energy Services Reunited Corp
NESR
$3.53B
| $2.61M | ﹤0.01% |
+249,913
| New | +$2.21M |
|
2203
Descartes Systems
DSGX
$6.91B
| $2.61M | ﹤0.01% |
71,755
+22,570
| +46% | +$730K |
|
|
FOMX
2204
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $2.61M | ﹤0.01% |
695,489
-357,252
| -34% | -$1.34M |
|
|
EXAS
2205
PUT
DELISTED
Exact Sciences
EXAS
| $2.6M | ﹤0.01% |
+30,000
| New | +$2.55M |
|
|
KBAL
2206
DELISTED
Kimball International
KBAL
| $2.6M | ﹤0.01% |
183,681
+110,954
| +153% | +$1.66M |
|
|
QIWI
2207
DELISTED
QIWI PLC
QIWI
| $2.59M | ﹤0.01% |
180,215
-93,344
| -34% | -$1.37M |
|
2208
Schwab Short-Term US Treasury ETF
SCHO
$13.1B
| $2.59M | ﹤0.01% |
103,160
+84,268
| +446% | +$2.1M |
|
|
BCPC
2209
Balchem Corp
BCPC
$5.67B
| $2.59M | ﹤0.01% |
27,897
+23,517
| +537% | +$2.03M |
|
2210
Cognex
CGNX
$10.6B
| $2.59M | ﹤0.01% |
50,888
+25,282
| +99% | +$1.21M |
|
2211
Herbalife
HLF
$1.29B
| $2.59M | ﹤0.01% |
48,809
-90,249
| -65% | -$5.18M |
|
2212
Ambarella
AMBA
$3.12B
| $2.58M | ﹤0.01% |
59,802
+44,086
| +281% | +$1.74M |
|
2213
Skywest
SKYW
$3.84B
| $2.58M | ﹤0.01% |
47,519
+41,710
| +718% | +$2.14M |
|
|
SEI
2214
Solaris Energy Infrastructure
SEI
$3.48B
| $2.58M | ﹤0.01% |
156,750
+141,650
| +938% | +$2.17M |
|
|
TIGR
2215
UP Fintech Holding
TIGR
$910M
| $2.58M | ﹤0.01% |
+199,100
| New | +$2.33M |
|
|
CMCM
2216
Cheetah Mobile
CMCM
$92.8M
| $2.57M | ﹤0.01% |
80,182
-6,879
| -8% | -$234K |
|
2217
LifeVantage
LFVN
$81.4M
| $2.57M | ﹤0.01% |
+180,003
| New | +$2.61M |
|
|
TIVO
2218
DELISTED
Tivo Inc
TIVO
| $2.57M | ﹤0.01% |
275,832
-11,655
| -4% | -$121K |
|
|
NEBUU
2219
DELISTED
Nebula Acquisition Corporation Unit
NEBUU
| $2.56M | ﹤0.01% |
250,000
| – | – |
|
2220
ProQR Therapeutics
PRQR
$327M
| $2.56M | ﹤0.01% |
184,466
+93,968
| +104% | +$1.4M |
|
2221
Scotiabank
BNS
$113B
| $2.56M | ﹤0.01% |
48,002
-115,065
| -71% | -$6.3M |
|
|
NUVA
2222
DELISTED
NuVasive, Inc.
NUVA
| $2.56M | ﹤0.01% |
44,998
-285,011
| -86% | -$15.1M |
|
2223
PUT
Axsome Therapeutics
AXSM
$10.8B
| $2.55M | ﹤0.01% |
+179,500
| New | +$1.67M |
|
2224
CTS Corp
CTS
$1.65B
| $2.55M | ﹤0.01% |
86,705
+74,748
| +625% | +$2.19M |
|
|
PTLA
2225
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.54M | ﹤0.01% |
+73,172
| New | +$2.11M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $10.1B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.